Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. - Wikidata - awgldk - TriplyDB

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy.

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy.

http://www.wikidata.org/entity/Q33920295

about

Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play Metabolic Alterations Associated to Brain Dysfunction in Diabetes Recent advances in the application of metabolomics to Alzheimer's Disease Metabolic disturbances in diseases with neurological involvement Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease Altered reward circuitry in the norepinephrine transporter knockout mouse Altered neurocircuitry in the dopamine transporter knockout mouse brain Effects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AβPPswe-PS1dE9 mice Animal models and high field imaging and spectroscopy MICEST: a potential tool for non-invasive detection of molecular changes in Alzheimer's disease Current neuroimaging techniques in Alzheimer's disease and applications in animal models Proton MRS in mild cognitive impairment.A longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AβPPswe-PS1dE9 mice Magnetic resonance spectroscopy in common dementias Effect of Carr-Purcell refocusing pulse trains on transverse relaxation times of metabolites in rat brain at 9.4 Tesla.Hippocampal neurochemical changes in senescent mice induced with chronic injection of D-galactose and NaNO₂: an in vitro high-resolution NMR spectroscopy study at 9.4T.Neuroimaging in repetitive brain trauma.Metabolic properties in stroked rats revealed by relaxation-enhanced magnetic resonance spectroscopy at ultrahigh fields.A review of β-amyloid neuroimaging in Alzheimer's disease.Measurement of transverse relaxation times of J-coupled metabolites in the human visual cortex at 4 T.Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.Diabetes and Cognitive Impairment.In vivo 1H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment Multivariate statistical mapping of spectroscopic imaging data Detection of increased scyllo-inositol in brain with magnetic resonance spectroscopy after dietary supplementation in Alzheimer's disease mouse models.Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice.Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation.Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1.APPswe/PS1dE9 mice with cortical amyloid pathology show a reduced NAA/Cr ratio without apparent brain atrophy: A MRS and MRI study Anti-inflammatory treatment in AD mice protects against neuronal pathology.Magnetic resonance imaging of the Amine-Proton EXchange (APEX) dependent contrast.Brain diabetic neurodegeneration segregates with low intrinsic aerobic capacity Magnetic resonance spectroscopy in vivo of neurochemicals in a transgenic model of Alzheimer's disease: a longitudinal study of metabolites, relaxation time, and behavioral analysis in TASTPM and wild-type mice.Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders.Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults.Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice Age-related alterations in the metabolic profile in the hippocampus of the senescence-accelerated mouse prone 8: a spontaneous Alzheimer's disease mouse model.Proton MR spectroscopy-detectable major neurotransmitters of the brain: biology and possible clinical applications.

P2860

Q24305472-E1A24CC6-3418-4F17-B519-218F365A5CB8 Q24594531-FCD314C2-AC2C-46F0-89C4-DF17A90DE584 Q26783376-7CAFE55B-B904-4518-ABFD-771D5BD4DE95 Q26828606-DE49C191-0E99-4390-AC09-FE3FCC64A263 Q26999015-75888997-1B4D-4B5D-A47A-A27AF1295E39 Q27307877-007018EF-298D-4D02-9170-96EF3EC2FC5E Q27312593-825FE01D-F7A9-4DFB-8AD7-34E3EE47E376 Q27324017-F89CFB24-6FE1-47F0-A33F-BD4F983DE10D Q28533783-BA0014E9-B366-4F30-9369-1E4E5B432715 Q28662048-BE07EBDE-58F1-4B70-9464-D22B63C74E5C Q30572242-91F2A4ED-53FE-416B-B6CD-9754BED72BBE Q30576714-B9A0507D-BA13-49CC-A12A-86FCA29A6842 Q30606675-0EEE5281-0DD2-4734-BCC6-C28DAAF6B3E6 Q30635401-26B41C05-2E48-499D-8AE4-3A2A7DF0A469 Q30660402-BF60A03D-79A4-4F78-AD11-238999FE7193 Q30736022-2BEF69F4-1C00-4944-85E5-3E782EE51263 Q30758233-A859EFEC-89B4-4E90-A2BD-F52CDD33A7E2 Q30836857-BF9AF047-7F08-4AE6-8407-56E86208A6C6 Q30852370-3F330D04-117B-436E-8480-BFD443B23564 Q30870063-387A4978-4AD4-4E58-8BC5-C9406A3AA22E Q31022757-CCBB5F3B-8A87-43B5-940C-5AB6DD2EAD7C Q31093609-249F45CB-2BB2-444A-8213-4262514B36AD Q31119662-8E6A499C-430E-4823-900A-DBBF1B29B454 Q33427621-C0B86755-52A0-491E-B658-50D9AD2933FF Q33517037-6B922590-3146-41C5-85A2-2C1588541269 Q33558132-53B9695B-289E-42BB-B74F-28414FBBEF97 Q33724870-E528C026-5D4B-450F-8B1D-F262664B68FC Q33757934-1D842675-0CDD-4787-B48A-766FD9AACE26 Q33758282-C77F370A-BFD5-42E7-AAA2-819BED995EA9 Q33812308-2F7A0208-BAFC-4FAE-AFCC-F54DE512D3B5 Q33828970-B0A89EF7-3379-4E73-A24D-94D24EE76AD1 Q34003975-A8EE5641-7789-475F-9FDA-4D70BF71449F Q34286417-F2C1F4EE-31A6-4965-852B-F9D1419D5476 Q34325302-E51F75A4-0328-4EFE-A871-55BCD59D8CE9 Q34372998-27A4B9C7-80D3-40AE-9BEF-0375DEA0115E Q35210272-E1FD1068-CDC4-4427-AFB7-5F76D92EEB67 Q35495245-C83991EF-EBE9-480A-A860-AAE49A30571D Q35565488-1A538F62-694A-4783-A82B-41E402FDFBF4 Q35939827-F037FF70-FC7A-4EBB-997C-C03D5F8300BA Q36232627-E1E2F1AB-BF90-4F44-9596-2056299A0ACE

P2860

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy.

http://www.wikidata.org/entity/Q33920295

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Monitoring disease progression ...... gnetic resonance spectroscopy.

@ast

Monitoring disease progression ...... gnetic resonance spectroscopy.

@en

type

label

Monitoring disease progression ...... gnetic resonance spectroscopy.

@ast

Monitoring disease progression ...... gnetic resonance spectroscopy.

@en

prefLabel

Monitoring disease progression ...... gnetic resonance spectroscopy.

@ast

Monitoring disease progression ...... gnetic resonance spectroscopy.

@en

P1433

Q33920295-DC5379A4-2C4C-424F-8F81-079EB007CE09

P1476

Q33920295-C22BE7A5-66C2-4DE0-8A44-39D1AC243D04

P2093

Q33920295-10947FDF-B833-45C3-9865-8BAB1F10F153

Q33920295-19D678A0-F5E8-4D4E-B3D6-8BBFB970DDF2

Q33920295-207D42B4-7188-455F-990F-28ECBDE9AABB

Q33920295-45726E5C-8902-4888-81A1-F1DCFF5FA05E

Q33920295-7B2660A9-4776-4D74-9249-44E84820F414

Q33920295-815DAAF5-5527-4205-8EED-B340AEA5624F

Q33920295-90D83EAC-D0DC-48D2-A7A6-E49CF50F9D92

Q33920295-FA4C76CA-131E-4CC0-870F-5D128FA82956

P2860

Q33920295-01BF3FEC-AB46-41D7-9403-36EAABBBCF52

Q33920295-0314998E-249B-4241-ADB4-6E3C5897030E

Q33920295-1AEBA3E8-BB03-41C2-94B2-DDFF174DAC12

Q33920295-23D5DEC3-E2CD-4709-AB39-BB4C1D03452D

Q33920295-29C90C46-FEFF-4DDA-9DC5-881F09AFCAF1

Q33920295-2A1E4E8B-2AF0-4B99-9A83-9FD7B0333464

Q33920295-2B0F19B2-9D40-4419-92C7-B70A714C2C6C

Q33920295-34291887-0A1C-430B-9829-20E54363EA52

Q33920295-40CA5285-8A02-42F2-BF28-039FFAB42F1A

Q33920295-4684904D-0091-427C-9309-9E7D32FC8529

P304

Q33920295-CFEC09B8-802F-46F9-A013-AD89220258E2

P31

Q33920295-A5090DDD-F291-4358-B5C3-6A8BF82DA5D3

P356

Q33920295-52CFA7CD-FCF3-4C24-9433-7EF2BAC797D5

P407

Q33920295-BD46883C-02F8-40AC-86C1-BA0467C32B1B

P433

Q33920295-DB276EAF-8776-4400-8502-B34E1E235AE6

P478

Q33920295-A47DE9C0-E7D8-4015-B301-823E900F727D

P50

Q33920295-ACF5C06B-49A4-4AFE-9F7A-915A9C05A0DC

P577

Q33920295-EE453ED9-E453-435C-8240-DA7A36E82452

P5875

Q33920295-8E46F696-10E8-4A58-A4AD-25BFDA83ECDE

P698

Q33920295-8C3E0DEB-7D77-41FD-86F9-3F631B6E29E0

P921

Q33920295-F14742A8-DEC7-4376-B23E-7F7B2DDBE85F

P932

Q33920295-DFA8009D-770F-4CFF-8618-BB277E9CF3E0

P356

PNAS.0505513102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Monitoring disease progression ...... gnetic resonance spectroscopy.

@en

P2093

Geoffrey L Curran

http://www.w3.org/2001/XMLSchema#string

Joseph F Poduslo

http://www.w3.org/2001/XMLSchema#string

Kâmil Ugurbil

http://www.w3.org/2001/XMLSchema#string

Malgorzata Marjanska

http://www.w3.org/2001/XMLSchema#string

Michael Garwood

http://www.w3.org/2001/XMLSchema#string

Pierre-Gilles Henry

http://www.w3.org/2001/XMLSchema#string

Robin L Bliss

http://www.w3.org/2001/XMLSchema#string

Thomas M Wengenack

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1

In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time.

In vivo MR spectroscopy of human dementia.

Automatic, localized in vivo adjustment of all first- and second-order shim coils.

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

Proton NMR chemical shifts and coupling constants for brain metabolites.

In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent

P304

11906-11910

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0505513102

http://www.w3.org/2001/XMLSchema#string

P407

P433

33

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7669811

http://www.w3.org/2001/XMLSchema#string

P698

16091461

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1188012

http://www.w3.org/2001/XMLSchema#string